Christopher Silber

Christopher Silber

Plus aucun poste en cours

Health Technology
Consumer Services

Profil

Christopher Silber worked as a Principal at Hospira, Inc. He then served as the Vice President-Clinical Affairs at OVATION Pharmaceuticals, Inc. from 2008 to 2010.
Later, he held the position of Senior Vice President-Clinical Development at SAGE Therapeutics, Inc. from 2017 to 2020.
Dr. Silber also worked as the Chief Medical Officer at Nocion Therapeutics, Inc. Currently, he is the Chief Medical Officer at Vigil Neuroscience, Inc. Dr. Silber completed his undergraduate studies at Tufts University and obtained a doctorate degree from Jacobs School of Medicine & Biomedical Sciences.

Anciens postes connus de Christopher Silber

SociétésPosteFin
VIGIL NEUROSCIENCE, INC. Chief Tech/Sci/R&D Officer 20/03/2024
SAGE THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer -
Chief Tech/Sci/R&D Officer 29/03/2010
Chief Tech/Sci/R&D Officer -
HOSPIRA, INC. Corporate Officer/Principal -
Voir l'expérience en détail de Christopher Silber

Formation de Christopher Silber

Tufts University Undergraduate Degree
Jacobs School of Medicine & Biomedical Sciences Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Christopher Silber

Relations

25

Relations au 1er degré

7

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
SAGE THERAPEUTICS, INC.

Health Technology

VIGIL NEUROSCIENCE, INC.

Health Technology

Entreprise privées3

Health Technology

Health Technology

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Christopher Silber